References
- Hatfield, K. J.; Olsnes, A. M.; Gjertsen, B. T.; Bruserud, O. Curr Cancer Drug Targets 2005, 5, 229 https://doi.org/10.2174/1568009054064651
- Folkman, J. Nat. Med. 1995, 1, 27 https://doi.org/10.1038/nm0195-27
- Yoshiji, H.; Kuriyama, S.; Yoshii, J.; Ikenaka, Y.; Noguchi, R.; Hicklin, D. J.; Huber, J.; Nakatani, T.; Tsujinoue, H.; Yanase, K.; Imazu, H.; Fukui, H. Hepatology 2002, 35, 834 https://doi.org/10.1053/jhep.2002.32541
- Ravi, R.; Mookerjee, B.; Bhujwalla, Z. M.; Sutter, C. H.; Artemov, D.; Zeng, Q.; Dillehay, L. E.; Madan, A.; Semenza, G. L.; Bedi, A. Genes. Dev. 2000, 14, 34
- Fukuda, R.; Kelly, B.; Semenza, G. L. Cancer Res. 2003, 63, 2330
- Shukla, S.; MacLennan, G. T.; Fu, P.; Patel, J.; Marengo, S. R.; Resnick, M. I.; Gupta, S. Neoplasia 2004, 6, 390 https://doi.org/10.1593/neo.04112
- Loureiro, R. M.; D'Amore, P. A. Cytokine Growth Factor Rev. 2005, 16, 77 https://doi.org/10.1016/j.cytogfr.2005.01.005
- Zhang, Y.; Deng, Y.; Luther, T.; Muller, M.; Ziegler, R.; Waldherr, R.; Stern, D. M.; Nawroth, P. P. J. Clin. Invest. 1994, 94, 1320 https://doi.org/10.1172/JCI117451
- Poon, R. T.; Lau, C. P.; Ho, J. W.; Yu, W. C.; Fan, S. T.; Wong, J. Clin. Cancer Res. 2003, 9, 5339
- Versteeg, H. H.; Spek, C. A.; Peppelenbosch, M. P.; Richel, D. J. Mol. Med. 2004, 10, 6 https://doi.org/10.1007/s00894-003-0157-6
- Cho, S. Bull. Korean Chem. Soc. 2005, 26, 1823 https://doi.org/10.5012/bkcs.2005.26.11.1823
- Kim, C. W.; Lee, H. M.; Lee, T. H.; Kang, C.; Kleinman, H. K.; Gho, Y. S. Cancer Res. 2002, 62, 6312
- Park, J. E.; Lee do, H.; Lee, J. A.; Park, S. G.; Kim, N. S.; Park, B. C.; Cho, S. Biochem. Biophys. Res. Commun. 2005, 337, 1283 https://doi.org/10.1016/j.bbrc.2005.10.004
Cited by
- N-Myc Downstream-Regulated Gene 2 Induces Angiogenesis vol.28, pp.7, 2006, https://doi.org/10.5012/bkcs.2007.28.7.1206
- CD14 Acts as an Angiogenic Factor by Inducing Basic Fibroblast Growth Factor (bFGF) vol.28, pp.9, 2006, https://doi.org/10.5012/bkcs.2007.28.9.1613